NCT03695848View on ClinicalTrials.gov

Prognostic Value of DTI and fMRI of Cervical Myelopathy

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

September 26, 2018

Primary Completion Date

June 30, 2021

Study Completion Date

December 31, 2021

Conditions
Cervical Myelopathy
Interventions
DEVICE

MRI scan

Before decompresssion surgery, DTI and fMRI will be recorded by a FDA approved 3T MRI scanner (Philips Achieva)

Trial Locations (2)

Unknown

G Li, Hong Kong

The university of Hong Kong, Hong Kong

All Listed Sponsors
lead

The University of Hong Kong

OTHER

NCT03695848 - Prognostic Value of DTI and fMRI of Cervical Myelopathy | Biotech Hunter | Biotech Hunter